BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 34440165)

  • 1. Primary Tumor Sidedness, RAS and BRAF Mutations and MSI Status as Prognostic Factors in Patients with Colorectal Liver Metastases Treated with Surgery and Thermal Ablation: Results from the Amsterdam Colorectal Liver Met Registry (AmCORE).
    Dijkstra M; Nieuwenhuizen S; Puijk RS; Timmer FEF; Geboers B; Schouten EAC; Opperman J; Scheffer HJ; de Vries JJJ; Versteeg KS; Lissenberg-Witte BI; van den Tol MP; Meijerink MR
    Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermal Ablation Compared to Partial Hepatectomy for Recurrent Colorectal Liver Metastases: An Amsterdam Colorectal Liver Met Registry (AmCORE) Based Study.
    Dijkstra M; Nieuwenhuizen S; Puijk RS; Timmer FEF; Geboers B; Schouten EAC; Opperman J; Scheffer HJ; Vries JJJ; Swijnenburg RJ; Versteeg KS; Lissenberg-Witte BI; van den Tol MP; Meijerink MR
    Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34199556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeat Local Treatment of Recurrent Colorectal Liver Metastases, the Role of Neoadjuvant Chemotherapy: An Amsterdam Colorectal Liver Met Registry (AmCORE) Based Study.
    Dijkstra M; Nieuwenhuizen S; Puijk RS; Timmer FEF; Geboers B; Schouten EAC; Opperman J; Scheffer HJ; de Vries JJJ; Versteeg KS; Lissenberg-Witte BI; Meijerink MR; van den Tol MP
    Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved Outcomes of Thermal Ablation for Colorectal Liver Metastases: A 10-Year Analysis from the Prospective Amsterdam CORE Registry (AmCORE).
    Puijk RS; Dijkstra M; van den Bemd BAT; Ruarus AH; Nieuwenhuizen S; Geboers B; Timmer FEF; Schouten EAC; de Vries JJJ; van der Meijs BB; Nielsen K; Swijnenburg RJ; van den Tol MP; Versteeg KS; Lissenberg-Witte BI; Scheffer HJ; Meijerink MR
    Cardiovasc Intervent Radiol; 2022 Aug; 45(8):1074-1089. PubMed ID: 35585138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Thermal Ablation for Small-Size (0-3 cm) versus Intermediate-Size (3-5 cm) Colorectal Liver Metastases: Results from the Amsterdam Colorectal Liver Met Registry (AmCORE).
    Dijkstra M; van der Lei S; Puijk RS; Schulz HH; Vos DJW; Timmer FEF; Scheffer HJ; Buffart TE; van den Tol MP; Lissenberg-Witte BI; Swijnenburg RJ; Versteeg KS; Meijerink MR
    Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermal Ablation versus Stereotactic Ablative Body Radiotherapy to Treat Unresectable Colorectal Liver Metastases: A Comparative Analysis from the Prospective Amsterdam CORE Registry.
    Nieuwenhuizen S; Dijkstra M; Puijk RS; Timmer FEF; Nota IM; Opperman J; van den Bemd B; Geboers B; Ruarus AH; Schouten EAC; de Vries JJJ; Scheffer HJ; van Geel AM; van Waesberghe JHTM; Swijnenburg RJ; Versteeg KS; Lissenberg-Witte BI; van den Tol MP; Haasbeek CJA; Meijerink MR
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Prognostic Value of Primary Tumor Location in Stage III Colon Cancer With RAS and BRAF Mutational Status.
    Taieb J; Kourie HR; Emile JF; Le Malicot K; Balogoun R; Tabernero J; Mini E; Folprecht G; Van Laethem JL; Mulot C; Bouché O; Aparicio T; Michel P; Thaler J; Bridgewater J; Van Cutsem E; Perkins G; Lepage C; Salazar R; Laurent-Puig P;
    JAMA Oncol; 2018 Jul; 4(7):e173695. PubMed ID: 29167892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ablation of colorectal liver metastasis: Interaction of ablation margins and RAS mutation profiling on local tumour progression-free survival.
    Calandri M; Yamashita S; Gazzera C; Fonio P; Veltri A; Bustreo S; Sheth RA; Yevich SM; Vauthey JN; Odisio BC
    Eur Radiol; 2018 Jul; 28(7):2727-2734. PubMed ID: 29417253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Primary Tumor Location and Genomic Alterations on Survival Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Colorectal Peritoneal Metastases.
    Hamed AB; Shuai Y; Derby J; Holtzman MP; Ongchin M; Bartlett DL; Pingpank JF; Pai R; Singhi A; Choudry HA
    Ann Surg Oncol; 2023 Jul; 30(7):4459-4470. PubMed ID: 37085655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncological outcomes and predictors of radiofrequency ablation of colorectal cancer liver metastases.
    Wang CZ; Yan GX; Xin H; Liu ZY
    World J Gastrointest Oncol; 2020 Sep; 12(9):1044-1055. PubMed ID: 33005297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor prognosis of KRAS or BRAF mutant colorectal liver metastasis without microsatellite instability.
    Umeda Y; Nagasaka T; Mori Y; Sadamori H; Sun DS; Shinoura S; Yoshida R; Satoh D; Nobuoka D; Utsumi M; Yoshida K; Yagi T; Fujiwara T
    J Hepatobiliary Pancreat Sci; 2013 Feb; 20(2):223-33. PubMed ID: 23010994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.
    Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM
    Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anatomical resection improves relapse-free survival in colorectal liver metastases in patients with KRAS/NRAS/BRAF mutations or right-sided colon cancer: a retrospective cohort study.
    Chang W; Chen Y; Zhou S; Ren L; Xu Y; Zhu D; Tang W; Ye Q; Wang X; Fan J; Wei Y; Xu J
    Int J Surg; 2023 Oct; 109(10):3070-3077. PubMed ID: 37526097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer.
    Margonis GA; Buettner S; Andreatos N; Kim Y; Wagner D; Sasaki K; Beer A; Schwarz C; Løes IM; Smolle M; Kamphues C; He J; Pawlik TM; Kaczirek K; Poultsides G; Lønning PE; Cameron JL; Burkhart RA; Gerger A; Aucejo FN; Kreis ME; Wolfgang CL; Weiss MJ
    JAMA Surg; 2018 Jul; 153(7):e180996. PubMed ID: 29799910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-institutional analysis of outcomes for thermosphere microwave ablation treatment of colorectal liver metastases: the SMAC study.
    De Cobelli F; Calandri M; Della Corte A; Sirovich R; Gazzera C; Della Vigna P; Bonomo G; Varano GM; Maiettini D; Mauri G; Camisassi N; Steidler S; Ratti F; Gusmini S; Ronzoni M; Aldrighetti L; Odisio BC; Racca P; Fonio P; Veltri A; Orsi F
    Eur Radiol; 2022 Jun; 32(6):4147-4159. PubMed ID: 35092474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of RAS and BRAF mutations in metastatic colorectal cancer patients by tumor sidedness: A systematic review and meta-analysis.
    Bylsma LC; Gillezeau C; Garawin TA; Kelsh MA; Fryzek JP; Sangaré L; Lowe KA
    Cancer Med; 2020 Feb; 9(3):1044-1057. PubMed ID: 31856410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant Chemotherapy Followed by Radiofrequency Ablation Prolongs Survival for Ablatable Colorectal Liver Metastasis: A Propensity Score Matching Comparative Study.
    Chen Y; Xu Y; Xu L; Han F; Huang Y; Jiang H; Wu J; Zhang Y
    Front Oncol; 2021; 11():758552. PubMed ID: 34745996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary tumour location affects survival after resection of colorectal liver metastases: A two-institutional cohort study with international validation, systematic meta-analysis and a clinical risk score.
    Gasser E; Braunwarth E; Riedmann M; Cardini B; Fadinger N; Presl J; Klieser E; Ellmerer P; Dupré A; Imai K; Malik H; Baba H; Ulmer H; Schneeberger S; Öfner D; Dinnewitzer A; Stättner S; Primavesi F
    PLoS One; 2019; 14(5):e0217411. PubMed ID: 31150437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propofol Compared to Midazolam Sedation and to General Anesthesia for Percutaneous Microwave Ablation in Patients with Hepatic Malignancies: A Single-Center Comparative Analysis of Three Historical Cohorts.
    Puijk RS; Ziedses des Plantes V; Nieuwenhuizen S; Ruarus AH; Vroomen LGPH; de Jong MC; Geboers B; Hoedemaker-Boon CJ; Thöne-Passchier DH; Gerçek CC; de Vries JJJ; van den Tol PMP; Scheffer HJ; Meijerink MR
    Cardiovasc Intervent Radiol; 2019 Nov; 42(11):1597-1608. PubMed ID: 31243542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic features and treatment efficacy of Chinese patients with BRAF-mutated metastatic colorectal cancer: a retrospective observational study.
    Wang X; Wei Q; Gao J; Li J; Li J; Gong J; Li Y; Shen L
    Chin J Cancer; 2017 Oct; 36(1):81. PubMed ID: 29037218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.